2024-09-10 HC Andersen – Q&A with Magnus Corfitzen Magnus Corfitzen, CEO presents at HC Andersen - Final outcome of Rights issue
2024-08-22 Carnegie – Interview CEO Magnus Corfitzen presents at Carnegie sharing insights on strong phase 3 results, rationale for the Rights issue 2024 and key milestones ahead
2024-08-22 Interview with Redeye Magnus Corfitzen, CEO at Ascelia Pharma AB shared his insights on the timeline for the NDA submission of Orviglance and the ongoing Rights Issue.
2024-08-22 HC Andersen – Update on Q2 2024 and Rights issue Julie Waras Brogren, Deputy CEO presents at HC Andersen
2024-08-13 HC Andersen Podcast – Business update Magnus Corfitzen, CEOpresent at the HC Andersen Podcast
2024-06-17 Ascelia Pharma – Commercial and partnership strategy Julie Waras Brogren, Deputy CEO presents at HC Andersen
2024-06-12 Interview with Redeye: commercial update and progress after successful Sparkle results Deputy CEO Julie Waras Brogren presents at Redeye
2024-06-04 HC Andersen – Life Science Seminar Magnus Corfitzen, CEO presents at the Life Science Seminar
2024-05-27 Penser by Carnegie- Healthcare event CEO Magnus Corfitzen presents at Erik Penser by Carnegie Company Day.
2024-05-23 HC Andersen – Presentation of Q1 2024 report Julie Waras Brogren, Deputy CEO presents the quarterly report Q1 2024
2024-05-14 HC Andersen – Podcast Magnus Corfitzen, CEO and Andreas Norlin CSO present at the HC Andersen Podcast, Ascelia Pharma strong superiority of Orviglance Phase 3 study
2024-04-16 Interview with Redeye Magnus Corfitzen, CEO at Ascelia Pharma AB met with Redeye. In this interview, Magnus elaborated on the recent completion of the image reading phase for the SPARKLE Phase 3 re-evaluation study and provided insights into what to expect for the upcoming headline results.
2024-03-07 Penser by Carnegie- Company Day CEO Magnus Corfitzen presents at Erik Penser by Carnegie Company Day.
2024-02-20 Penser by Carnegie- Company Status Update CEO and Deputy CEO present at Erik Penser by Carnegie.
2024-01-04 Interview with Redeye – Progress on the SPARKLE image re-evaluation CEO Magnus Corfitzen gives an interview at Redeye
2023-11-23 Redeye Life Science Day Deputy CEO Julie Waras Brogren presents at Redeye Life Science Day